SecuritySGYP / Synergy Pharmaceuticals, Inc.
InstitutionSusquehanna International Group, Llp
Shares1,923,375
Value $ 3,520,000
Related 871639AA8 / Synergy Pharmaceuticals, Inc., 7.5% Convertible Bond due 2019
SGYPW / Synergy Pharmaceuticals, Inc., Warrants

Susquehanna International Group, Llp reports 86.56% decrease in ownership of SGYP / Synergy Pharmaceuticals, Inc.

May 15, 2018 - Susquehanna International Group, Llp has filed a 13F-HR form disclosing ownership of 1,923,375 shares of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) with total holdings valued at $3,520,000 USD as of March 31, 2018. Susquehanna International Group, Llp had filed a previous 13F-HR on February 14, 2018 disclosing 14,312,160 shares of Synergy Pharmaceuticals, Inc. at a value of $31,916,000 USD. This represents a change in shares of -86.56 percent and a change in value of -88.97 percent during the quarter.

Susquehanna International Group, Llp has a history of taking positions in derivatives of the underlying security (SGYP) in the form of stock options. The firm currently holds 193,000 call options valued at $353,000 USD and 1,712,500 put options valued at $3,134,000 USD .

Other investors with positions similar to Susquehanna International Group, Llp include Hikari Power Ltd, JP Morgan Chase & Co, Geode Capital Management, Llc, Cvi Holdings, Llc, Northern Trust Corp, and Morgan Stanley.

Synergy Pharmaceuticals, Inc. has declared a standard industrial code (sic) of 2834 which is the "Pharmaceutical Preparations" industry. Susquehanna International Group, Llp's top industries are "Miscellaneous Repair Services" (sic 76), "Legal Services" (sic 81), and "Social Services" (sic 83).

Susquehanna International Group, Llp reports 86.56% decrease in  ownership of SGYP / Synergy Pharmaceuticals, Inc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 2.03 1,923,375 -86.56 3,520 -88.97 -25,150 -3,246 -10.17
2017-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 2.56 14,312,160 465.87 31,916 335.12 30,223 -5,642 -76.92
2017-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 3.68 2,529,222 5.57 7,335 -31.20 491 -3,817 -35.80
2017-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 4.56 2,395,710 -29.49 10,661 -32.67 -4,564 -608 -3.84
2017-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 5.38 3,397,694 203.68 15,833 132.36 12,249 -3,230 -47.40
2016-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 5.80 1,118,822 217.53 6,814 251.06 4,445 428 22.04
2016-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 4.65 352,354 -24.89 1,941 8.86 -544 702 39.35
2016-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 3.28 469,148 120.22 1,783 203.23 840 355 60.35
2016-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 4.22 213,038 -12.84 588 -57.58 -132 -666 -48.03
2015-12-31 13F-HR/A-1 SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 5.48 244,421 0.15 1,386 7.19 2 91 7.03
2015-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 244,421 1,386
2015-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 6.80 244,049 1,111.82 1,293 674.25 1,522 -396 -236.83
2015-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 6.46 20,139 -91.61 167 -84.94 -1,420 478 43.08
2015-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 3.83 240,038 80.57 1,109 173.83 411 293 72.45
2014-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 2.92 132,934 -52.31 405 -47.81 -425 54 6.96
2014-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 3.43 278,722 1.96 776 -30.22 18 -354 -31.86
2014-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 4.07 273,373 1,112 393 -0 -0.04

Call Options

Effective
Date
Form Security Class CUSIP Opt Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 2.03 193,000 -24.22 353 -37.85 -125 -90 -15.81
2017-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 2.56 254,700 66.58 568 28.22 261 -136 -30.70
2017-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 3.67 152,900 -31.71 443 -55.52 -261 -292 -29.34
2017-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 4.55 223,900 -54.49 996 -56.56 -1,221 -76 -3.31
2017-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 5.37 492,000 56.69 2,293 19.93 957 -576 -30.11
2016-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 5.80 314,000 51.84 1,912 67.87 622 151 13.29
2016-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 4.66 206,800 124.05 1,139 224.50 533 255 72.64
2016-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 3.28 92,300 -2.02 351 35.00 -6 97 37.40
2016-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 4.22 94,200 -52.30 260 -76.79 -435 -425 -37.91
2015-12-31 13F-HR/A SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 5.48 197,500 -28.08 1,120 -23.02 -423 88 6.04
2015-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 188,200 1,067
2015-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 6.80 274,600 -46.76 1,455 -66.01 -1,640 -1,186 -27.70
2015-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 6.46 515,800 1,142.89 4,281 2,129.69 3,065 1,024 533.10
2015-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 41,500 192 192 0
2014-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 0 -100.00 0 -100.00 0 0
2014-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 3.43 109,400 -38.09 305 -57.58 -231 -183 -25.49
2014-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Call 176,700 719

Put Options

Effective
Date
Form Security Class CUSIP Opt Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 2.03 1,712,500 -19.15 3,134 -33.64 -823 -766 -16.22
2017-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 2.57 2,118,000 39.77 4,723 7.46 1,546 -1,218 -27.71
2017-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 3.68 1,515,400 10.10 4,395 -28.24 511 -2,241 -36.59
2017-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 4.56 1,376,400 -12.60 6,125 -16.54 -904 -310 -4.23
2017-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 5.38 1,574,800 180.36 7,339 114.53 5,446 -1,528 -44.66
2016-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 5.80 561,700 34.19 3,421 48.35 830 285 12.36
2016-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 4.65 418,600 -10.65 2,306 29.55 -232 758 42.60
2016-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 3.28 468,500 80.47 1,780 148.60 685 379 52.94
2016-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 4.21 259,600 -48.56 716 -74.98 -1,033 -1,113 -38.89
2015-12-31 13F-HR/A SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 5.49 504,700 -22.77 2,862 -17.38 -816 214 6.19
2015-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 485,900 2,755
2015-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 6.80 653,500 18.34 3,464 -24.42 689 -1,808 -39.45
2015-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 6.46 552,200 350.04 4,583 708.29 2,775 1,241 218.92
2015-03-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 3.83 122,700 344.57 567 575.00 364 119 141.13
2014-12-31 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 2.91 27,600 -64.43 84 -61.11 -146 14 6.33
2014-09-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 3.43 77,600 -49.87 216 -65.71 -265 -149 -23.72
2014-06-30 13F-HR SYNERGY PHARMACEUTICALS DEL COM NEW 871639308 Put 154,800 630
SGYP: Synergy Pharmaceuticals Stock Analysis and Research Report

2017-09-29 - Asif

Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies. The company has pioneered discovery, research and development efforts around analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. The company discovered, are developing and control 100% worldwide rights to its proprietary uroguanylin based GI platform, which includes one commercial product, TRULANCE (plecanatide), and a second product candidate, dolcanatide. TRULANCE (plecanatide) Its first and only commercial product, TRULANCE™, is approved and marketed in the United States (U.S.), under the trademark name TRULANCE™, as a once-daily treatment for adults with chronic idiopathic constipation, or CIC. In clinical trials, TRULANCE helped improve stool consistency and provide more regular bowel movements. TRULANCE is the only prescription medication for CIC that c...



CUSIP: 871639308